Replies to post #15105 on Innovus Pharmaceuticals Inc. (fka INNV)

[jtaylor68]

There's no need to discuss anything about this ANDA. It comes when it comes, be this year or the next year.

Nothing was rejected. That's a matter of fact. A rejection is a material event and thus requires disclosure. This is not debatable.

How do you know there were no issues with the Rx version?